Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study
The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Nosocomial bloodstream infections (BSIs) are important causes of morbidity and mortality in the United States. METHODS: Data from a nationwide, concurrent surveillance study (Surveillance and Control of Pathogens of Epidemiological Importance [SCOPE]) were used to examine the secular trends in the epidemiology and microbiology of nosocomial BSIs. RESULTS: Our study detected 24,179 cases of nosocomial BSI in 49 US hospitals over a 7-year period from March 1995 through September 2002 (60 cases per 10,000 hospital admissions). Eighty-seven percent of BSIs were monomicrobial. Gram-positive organisms caused 65% of these BSIs, gram-negative organisms caused 25%, and fungi caused 9.5%. The crude mortality rate was 27%. The most-common organisms causing BSIs were coagulase-negative staphylococci (CoNS) (31% of isolates), Staphylococcus aureus (20%), enterococci (9%), and Candida species (9%). The mean interval between admission and infection was 13 days for infection with Escherichia coli, 16 days for S. aureus, 22 days for Candida species and Klebsiella species, 23 days for enterococci, and 26 days for Acinetobacter species. CoNS, Pseudomonas species, Enterobacter species, Serratia species, and Acinetobacter species were more likely to cause infections in patients in intensive care units (P<.001). In neutropenic patients, infections with Candida species, enterococci, and viridans group streptococci were significantly more common. The proportion of S. aureus isolates with methicillin resistance increased from 22% in 1995 to 57% in 2001 (P<.001, trend analysis). Vancomycin resistance was seen in 2% of Enterococcus faecalis isolates and in 60% of Enterococcus faecium isolates. CONCLUSION: In this study, one of the largest multicenter studies performed to date, we found that the proportion of nosocomial BSIs due to antibiotic-resistant organisms is increasing in US hospitals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the United States and elsewhere, Candida species are a leading cause of health care–associated bloodstream infections (3–5).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [4]
In the citing paper
“The incidence of nosocomial candidiasis has increased over the past few decades [28,29,30,31,32].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [32]
In the citing paper
“Candidaemia is the most common form of invasive candidiasis associated with an unacceptably high mortality rates in excess of 40% even with the introduction of newer antifungal agents [30,32,33].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [32]
In the citing paper
“Data from a US surveillance study found that over a 7year period Candida spp.accounted for 4.6 bloodstream infections per 10,000 admissions and 9% of all bloodstream infections [1], whereas the incidence may vary between centers.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [1]
In the citing paper
“Among documented invasive fungal infections, candidemia and invasive candidiasis are encountered with increasing incidence in nosocomial settings [1].”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [1]
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779 · cited 1×
“[30] showed that mortality rates doubled, from 30% to 60%, when inappropriate empirical antibiotic therapy was given to ICU patients with BSIs.”
BackgroundNosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387 · cited 3×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundMethodSelf-citationDiekema, D. J., Pfaller, M. A., Schmitz, F. J., Smayevsky, J., Bell, J., Jones, R. N., Beach, M., & SENTRY Participants Group (2001) · Clinical Infectious Diseases · doi:10.1086/320184 · Cited by 1,362 · cited 1×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundWeinstein, M. P., Towns, M. L., Quartey, S. M., Mirrett, S., Reimer, L. G., Parmigiani, G., & Barth Reller, L. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.584 · Cited by 1,228 · cited 1×
“Recent studies have shown that the proportion of contaminants is lower if 2 or more positive blood culture results (of samples drawn within a few hours of each other) were required for inclusion [9, 32, 33].”
BackgroundPittet, D. (1994) · JAMA · doi:10.1001/jama.1994.03510440058033 · Cited by 926
Trick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660
Kreger, B. E., Craven, D. E., Carling, P. C., & McCabe, W. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90101-1 · Cited by 595 · cited 1×
“The crude rate mortality ranged from 12% in total hospital populations to 80% in ICU patients [6–10].”
BackgroundEmergence of Vancomycin Resistance in Coagulase-Negative Staphylococci
Schwalbe, R. S., Stapleton, J. T., & Gilligan, P. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704093161507 · Cited by 584 · cited 1×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundFridkin, S. K., Steward, C. D., Edwards, J. R., Pryor, E. R., McGowan, Jr., Archibald, L. K., Gaynes, R. P., & Tenover, F. C. (1999) · Clinical Infectious Diseases · doi:10.1086/520193 · Cited by 486
Research works printed but not linked: 1
- 1996, 77, 791, 10.1002/(SICI)1097-0142(19960215)77:4<791::AID-CNCR27>3.0.CO;2-V · DOI · Paper page
Cited by
Items 701–800 of 1,033
Time to positivity of blood cultures of different Candida species causing fungaemia
Lai, C.-C., Wang, C.-Y., Liu, W.-L., Huang, Y.-T., & Hsueh, P.-R. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.038166-0 · Cited by 74
“50 % of all cases, incidence rates of fungaemia caused by other species of Candida, including Candida tropicalis, Candida glabrata and Candida parapsilosis, are increasing (Abi-Said et al., 1997; Wisplinghoff et al., 2004; Ruan & Hsueh, 2009).”
BackgroundPemán, J., Cantón, E., Linares-Sicilia, M. J., Roselló, E. M., Borrell, N., Ruiz-Pérez-de-Pipaon, M. T., Guinea, J., García, J., Porras, A., García-Tapia, A. M., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05474-11 · Cited by 75
“The incidence of bloodstream fungal infection, in adults and pediatric patients, has risen in the last decade as a result of a combination of several factors, such as increased use of central venous catheters, extensive use of parenteral nutrition, mucosa alteration or prolonged neutropenia due to more aggressive anti…”
BackgroundMechanisms of NDV-3 vaccine efficacy in MRSA skin versus invasive infection
Yeaman, M. R., Filler, S. G., Chaili, S., Barr, K., Wang, H., Kupferwasser, D., Hennessey, J. P., Fu, Y., Schmidt, C. S., Edwards, J. E., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415610111 · Cited by 76
“aureus is now the second most common bloodstream isolate in healthcare settings (11), and SSSI is a frequent source of invasive infections such as pneumonia or endocarditis (12, 13).”
Santimaleeworagun, W., Wongpoowarak, P., D, P. C. M., Pattharachayakul, S., Tansakul, P., & Garey, K. W. (2011) · PubMed · Cited by 75
Gorityala, B. K., Guchhait, G., Goswami, S., Fernando, D. M., Kumar, A., Zhanel, G. G., & Schweizer, F. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00867 · Cited by 75
Singer, J. P., Blanc, P. D., Hoopes, C., Golden, J. A., Koff, J. L., Leard, L. E., Cheng, S., & Chen, H. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03684.x · Cited by 75
Procalcitonin levels in surgical patients at risk of candidemia
Martini, A., Gottin, L., Menestrina, N., Schweiger, V., Simion, D., & Vincent, J. (2010) · Journal of Infection · doi:10.1016/j.jinf.2010.03.003 · Cited by 83
Candida infection of the central nervous system following neurosurgery: a 12-year review
O’Brien, D. J., Stevens, N. T., Lim, C. H., O’Brien, D. F., Smyth, E. G., Fitzpatrick, F., & Humphreys, H. (2011) · Acta Neurochirurgica · doi:10.1007/s00701-011-0990-9 · Cited by 76
“are emerging as a significant cause of healthcare-associated infection (HCAI) and are now the fourth leading pathogen of nosocomial bloodstream infection in the United States [16].”
BackgroundPereira, C. A. P., Marra, A. R., Camargo, L. F. A., Pignatari, A. C. C., Sukiennik, T., Behar, P. R. P., Medeiros, E. A., Ribeiro, J. F., Girão, E. S., Corrêa, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068144 · Cited by 74
“, ICU, neutropenic, or haemodialysis patients) [9,10,11].”
BackgroundMethodResultInfluentialSelf-citationWiederhold, N. P., Najvar, L. K., Bocanegra, R., Molina, D., Olivo, M., & Graybill, J. R. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00105-07 · Cited by 75
“Invasive candidiasis caused by Candida glabrata is of increasing clinical concern due to reports of the increasing frequency of cases and the high mortality rates in patients with multiple comorbidities, including elderly patients, immunocompromised patients with cancer, and patients in intensive care units (4, 15, 24…”
BackgroundPulse Field Gel Electrophoresis
Sharma‐Kuinkel, B. K., Rude, T. H., & Fowler, V. G. (2014) · Methods in molecular biology · doi:10.1007/7651_2014_191 · Cited by 90
“aureus is the second most common overall cause of healthcare-associated infections reported to the National Healthcare Safety Network, the most common cause of surgical site infections (10), the leading cause of infections involving heart valves and cardiac devices (11, 12), and a leading cause of bacteremia (13, 14)…”
Hattori, H., Maeda, M., Nagatomo, Y., Takuma, T., Niki, Y., Naito, Y., Sasaki, T., & Ishino, K. (2018) · American Journal of Infection Control · doi:10.1016/j.ajic.2018.06.019 · Cited by 84
“The prevalenceofAMRinEnterobacteriaceaewashigher inBrazil(23) andVietnam(7) than inother countries, and fungalBSIswerea significantcontributor tomortality in some reports.(3,23,24)Multivariate analysis in this study found that fungal BSIswere independently associatedwith 30-daymortality.”
BackgroundResultHancock, L. E., & Gilmore, M. S. (2014) · ASM Press eBooks · doi:10.1128/9781555816513.ch25 · Cited by 74
Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection
Klevay, M. J., Ernst, E. J., Hollanbaugh, J. L., Miller, J. G., Pfaller, M. A., & Diekema, D. J. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.10.001 · Cited by 73
“have emerged as the 4th most common cause of nosocomial bloodstream infection (BSI) (Wisplinghoff et al., 2004).”
BackgroundEpidemiology of bacteraemia in Hamad general hospital, Qatar: A one year hospital-based study
Khan, F. Y., Elshafie, S. S., Almaslamani, M., Abukhattab, M., Ah, E.-H., Errayes, M., & Maslamani, E. A. (2010) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2010.10.004 · Cited by 73
Muñoz, J. F., Gauthier, G. M., Desjardins, C. A., Gallo, J. E., Holder, J. W., Sullivan, T. D., Marty, A. J., Carmen, J. C., Chen, Z., Ding, L., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005493 · Cited by 82
“Unlike opportunistic fungi, such as Candida albicans, Cryptococcus neoformans, or Aspergillus fumigatus, the dimorphic fungi can infect immunocompetent and immunocompromised hosts [6,9–11].”
Moellering, R. C., Graybill, J. R., McGowan, J. E., & Corey, L. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.04.001 · Cited by 84
Current Status and Future Perspectives on Molecular and Serological Methods in Diagnostic Mycology
Lau, A. F., Chen, W., Sleiman, S., & Sorrell, T. C. (2009) · Future Microbiology · doi:10.2217/fmb.09.70 · Cited by 80
Harris, D. M., & Hata, D. J. (2013) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-12-2 · Cited by 74
“5-32 days [2], and inappropriate empirical antimicrobial therapy is an important predictor of death in this patient population [3].”
BackgroundYang, S.-P., Chen, Y.-Y., Hsu, H., Wang, F., Chen, L.-Y., & Fung, C.-P. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-10 · Cited by 84
“Along with this trend, these infections occurred more often in the nonneutropenic, critically ill patients [5,7-9] than in those patients who were neutropenic or had received organ transplantation in the past.”
BackgroundCharretier, Y., Dauwalder, O., Franceschi, C., Degout-Charmette, E., Zambardi, G., Cecchini, T., Bardet, C., Lacoux, X., Dufour, P., Véron, L., et al. (2015) · Scientific Reports · doi:10.1038/srep13944 · Cited by 81
Systems Biology of Fungal Infection
Horn, F., Heinekamp, T., Kniemeyer, O., Pollmächer, J., Valiante, V., & Brakhage, A. A. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00108 · Cited by 73
Microbiological Profile of Organisms Causing Bloodstream Infection in Critically Ill Patients
Orsini (2012) · Journal of Clinical Medicine Research · doi:10.4021/jocmr1099w · Cited by 90
“Kett et al reported Candida albicans as the most common Candida spp isolated among patients in ICU’s [13, 39].”
BackgroundInfluentialImpact of bloodstream infections on catheter colonization during extracorporeal membrane oxygenation
Kim, D. W., Yeo, H. J., Yoon, S. H., Lee, S. E., Lee, S. J., Cho, W. H., Jeon, D., Kim, Y. S., Son, B. S., & Kim, D. H. (2015) · Journal of Artificial Organs · doi:10.1007/s10047-015-0882-5 · Cited by 73
“The organisms colonizing an ECMO catheter in the setting of primary BSI were Gram-positive cocci and Candida species, which are pathogens commonly observed in central venous catheter infections [22–24].”
BackgroundCandida biofilm production is associated with higher mortality in patients with candidaemia
Vitális, E., Nagy, F., Tóth, Z., Forgács, L., Bozó, A., Kardos, G., Majoros, L., & Kovács, R. (2020) · Mycoses · doi:10.1111/myc.13049 · Cited by 74
“Mean age (range) 61 (1-90) 63 (1-89) 61 (1-90) .”
Shi, W., Chen, Z., Chen, X., Cao, L., Liu, P., & Sun, S. (2010) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2010.00664.x · Cited by 71
“Several studies have estimated that 6–11% of all positive nosocomial bloodstream infections could be attributed to Candida spp. (Wisplinghoff et al., 2004; Pfaller & Diekema, 2007).”
BackgroundCandidaemia in a European Paediatric University Hospital: a 10-year observational study
Tragiannidis, A., Fegeler, W., Rellensmann, G., Debus, V., Müller, V., Hoernig-Franz, I., Siam, K., Pana, Z. D., Jürgens, H., & Groll, A. H. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03720.x · Cited by 84
“In contrast to adults [16,23] and similar to other paediatric reports [9,16], there was no apparent difference in mortality between C.”
ResultMarchaim, D., Zaidenstein, R., Lazarovitch, T., Karpuch, Y., Ziv, T., & Weinberger, M. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0545-z · Cited by 72
“While in most reports in the past from Europe and the US there is a persistent trend of a decrease in the proportion of bacteremia due to Gramnegative organisms [3, 13], there are few centers which report an opposite trend [14].”
BackgroundResultInfluentialVigil, K. J., Johnson, J. R., Johnston, B., Kontoyiannis, D. P., Mulanovich, V. E., RAAD, I. I., DuPont, H. L., & Adachi, J. A. (2009) · Clinical Infectious Diseases · doi:10.1086/649866 · Cited by 83
“Escherichia coli is the most common cause of gramnegative bacteremia [1], including among patients with cancer [2], and constitutes a serious threat to compromised hosts.”
BackgroundOverview of vertebrate animal models of fungal infection
Hohl, T. M. (2014) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.03.022 · Cited by 84
“Candida species are the fourth most common cause of nosocomial bloodstream infections in the United States (Wisplinghoff et al., 2004).”
BackgroundAnalytic Reviews: Prevention of Central Venous Catheter Bloodstream Infections
Walz, J. M., Memtsoudis, S. G., & Heard, S. O. (2010) · Journal of Intensive Care Medicine · doi:10.1177/0885066609358952 · Cited by 73
Widerström, M., Monsen, T., Karlsson, C., & Wiström, J. (2006) · Journal of Hospital Infection · doi:10.1016/j.jhin.2006.06.013 · Cited by 72
Jiménez-López, C., Collette, J. R., Brothers, K. M., Shepardson, K. M., Cramer, R. A., Wheeler, R. T., & Lorenz, M. C. (2013) · Eukaryotic Cell · doi:10.1128/ec.00290-12 · Cited by 74
“In individuals with compromised immunity, disseminated candidiasis may result in severe disease with a mortality approaching 40%, a rate that has not changed in decades (1, 2).”
BackgroundBrun‐Buisson, C., Fartoukh, M. S., Lechapt, E., Honoré, S., Zahar, J., Cerf, C., & Maître, B. (2005) · CHEST Journal · doi:10.1378/chest.128.2.533 · Cited by 73
Pseudomonas spp., Acinetobacter spp. and Miscellaneous Gram-Negative Bacilli
Wisplinghoff, H. (2016) · Elsevier eBooks · doi:10.1016/b978-0-7020-6285-8.00181-7 · Cited by 95
Self-citationDavis, S. L., Vazquez, J. A., & Mckinnon, P. S. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1h516 · Cited by 71
Occurrence, presentation and treatment of candidemia
Mikulska, M., Del Bono, V., Ratto, S., & Viscoli, C. (2012) · Expert Review of Clinical Immunology · doi:10.1586/eci.12.52 · Cited by 71
Changing epidemiology of candidaemia: Increase in fluconazole‐resistant Candida parapsilosis
Mesini, A., Mikulska, M., Giacobbe, D. R., Puente, F. D., Gandolfo, N., Codda, G., Orsi, A., Tassinari, F., Beltramini, S., Marchese, A. E., et al. (2020) · Mycoses · doi:10.1111/myc.13050 · Cited by 77
Fungemia in COVID‐19 ICU patients, a single medical center experience
Bishburg, E., Okoh, A., Nagarakanti, S. R., Lindner, M., Migliore, C., & Patel, P. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26633 · Cited by 70
“It seems that, both factors translated into a higher rate of bacterial superinfection and antibiotic utilization which are known risk factors for the development of candidemia.(5,13) The logistic regression analysis showed that, only days on mechanical ventilation was an independent predictor for development of candid…”
BackgroundNoto, M. J., Fox, P. M., & Archer, G. L. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01164-07 · Cited by 87
Idelevich, E. A., Grunewald, C. M., Wüllenweber, J., & Becker, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114834 · Cited by 75
“An approach of using very short-term cultures incubated only few hours after streaking of positive BC broth onto solid medium has recently been suggested for identification of BSI pathogens by MALDI-TOF [18].”
BackgroundInfluentialAtrouni, W. E., Knoll, B. M., Lahr, B. D., Eckel‐Passow, J. E., Sia, I. G., & Baddour, L. M. (2009) · Clinical Infectious Diseases · doi:10.1086/648442 · Cited by 71
Twilla, J. D., Finch, C. K., Usery, J. B., Gelfand, M. S., Hudson, J. Q., & Broyles, J. E. (2011) · Journal of Hospital Medicine · doi:10.1002/jhm.994 · Cited by 74
“nism in approximately 10% of all nosocomial bloodstream infections (BSIs).(1,2) In 2006, the Infectious Diseases Society of America identified vancomycinresistant Enterococcus faecium (VRE) as 1 of 6 microbes considered to be among the most dangerous”
BackgroundBiomaterials surfaces capable of resisting fungal attachment and biofilm formation
Coad, B. R., Kidd, S. E., Ellis, D. H., & Griesser, H. J. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.10.015 · Cited by 84
In Vitro Activities of the Rx-01 Oxazolidinones against Hospital and Community Pathogens
Lawrence, L. E., Danese, P. N., DeVito, J. A., Franceschi, F. J., & Sutcliffe, J. A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01383-07 · Cited by 77
“The frequency of antimicrobial-resistant microbes isolated in hospital and community settings is increasing worldwide (6, 25, 29, 36, 45, 50, 52, 57).”
BackgroundRamoplanin: a topical lipoglycodepsipeptide antibacterial agent
Fulco, P. P., & Wenzel, R. P. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.6.939 · Cited by 79
Self-citationZirkel, J., Klinker, H., Kuhn, A., Abele-Horn, M., Tappe, D., Turnwald, D., Einsele, H., & Heinz, W. J. (2012) · Medical Mycology · doi:10.3109/13693786.2011.587211 · Cited by 70
Variable recognition of Candida albicans strains by TLR4 and lectin recognition receptors
Netea, M. G., Gow, N. A. R., Joosten, L. A. B., Verschueren, I., van der Meer, J. W. M., & Kullberg, B. J. (2010) · Medical Mycology · doi:10.3109/13693781003621575 · Cited by 71
Thapaliya, D., Forshey, B. M., Kadariya, J., Quick, M. K., Farina, S. A., Brien, A. O., Nair, R., Amos, N., Hanson, B., Kates, A., et al. (2017) · Food Microbiology · doi:10.1016/j.fm.2017.01.015 · Cited by 71
“aureus accounts for nearly 20% of bloodstream infections in the hospital setting, and treatment of infections caused by this versatile and dangerous pathogen has become increasingly difficult due to the emergence ofmultidrug-resistant (MDR) strains, including those resistant to the antibiotic oxacillin (Lowy, 1998; Wi…”
Helm, R. E., Klausner, J. D., Klemperer, J. D., Flint, L. M., & Huang, E. (2019) · Journal of Infusion Nursing · doi:10.1097/nan.0000000000000326 · Cited by 71
Liu, Q., Li, W., Du, X., Li, W., Zhong, T., Tang, Y., Feng, Y., Tao, C., & Xie, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130701 · Cited by 74
Analysis of Candida auris fungemia at a single facility in Kenya
Adam, R. D., Revathi, G., Okinda, N., Fontaine, M., Shah, J., Kagotho, E., Castanheira, M., Pfaller, M. A., & Maina, D. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.06.001 · Cited by 72
Epidemiology and burden of invasive fungal infections in the countries of the Arab League
Kmeid, J., Jabbour, J.-F., & Kanj, S. S. (2019) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2019.05.007 · Cited by 74
Eugenol: A novel therapeutic agent for the inhibition of Candida species infection
Didehdar, M., Chegini, Z., & Shariati, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.872127 · Cited by 85
“albicans species collectively could represent >50% of the bloodstream isolates in certain regions (Wisplinghoff et al., 2004; Kullberg and Arendrup, 2015).”
BackgroundDeRyke, C. A., Kuti, J. L., & Nicolau, D. P. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.3.333 · Cited by 71
Li, B., Li, J., Pan, X., Ding, G., Cao, H., Jiang, W., Zheng, J., & Zhou, H. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.12.006 · Cited by 70
Walther‐Wenke, G., Schrezenmeier, H., Deitenbeck, R., Geis, G., Burkhart, J., Höchsmann, B., Sireis, W., Schmidt, M., Seifried, E., Gebauer, W., et al. (2009) · Annals of Hematology · doi:10.1007/s00277-009-0762-2 · Cited by 70
“Coagulase-negative staphylococci are by far the most commonly isolated agents [26-28].”
BackgroundYang, Z.-T., Wu, L., Liu, X.-Y., Zhou, M., Li, J., Wu, J.-Y., Cai, Y., Mao, E.-Q., Chen, E.-Z., & Lortholary, O. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-241 · Cited by 71
“are currently between the fourth and the sixth most common nosocomial bloodstream isolate in American and European studies [1,2].”
BackgroundKim, J., Gregson, D. B., Ross, T., & Laupland, K. B. (2010) · Journal of Infection · doi:10.1016/j.jinf.2010.06.001 · Cited by 75
Bahu, R. R., Chaftari, A., Hachem, R. Y., Ahrar, K., Shomali, W. E., Zakhem, A. E., Jiang, Y., Shuaibi, M. A., & RAAD, I. I. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.08.094 · Cited by 73
In Vitro Antibiofilm Activity of Eucarobustol E against Candida albicans
Liu, R.-H., Shang, Z.-C., Li, T.-X., Yang, M.-H., & Kong, L.-Y. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02707-16 · Cited by 68
“Candidiasis is the most frequently encountered fungal disease, with manifestations ranging from mild mucosal infections to serious candidemia and disseminated candidiasis (1, 2), and it is notoriously the second most common cause of death from nosocomial infections (3, 4).”
BackgroundPathirana, R. U., Friedman, J., Norris, H. L., Salvatori, O., McCall, A. D., Kay, J., & Edgerton, M. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01872-17 · Cited by 70
“the United States (1, 2), partly due to their intrinsic drug resistance.”
BackgroundShen, J., Cowen, L. E., Griffin, A. M., Chan, L., & Köhler, J. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809147105 · Cited by 71
“ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S”
BackgroundInfluentialGumbo, T., Drusano, G. L., Liu, W., Ma, L., Deziel, M. R., Drusano, M. F., & Louie, A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00507-06 · Cited by 71
“Candidemia is often fatal, especially when it is due to nonCandida albicans species (25, 27).”
BackgroundHospital acquired infections (HAI) in the elderly: Comparison with the younger patients
Avci, M., Ozgenc, O., Coskuner, S. A., & Olut, A. I. (2012) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2011.03.014 · Cited by 69
“aureus, penicillin-resistant Streptococcus pneumoniae, vancomycin-resistant enterococci, and multiple-drug-resistant gramnegative bacilli are emerging throughout the world as well as in Turkey in all health care institutions (Strausbaugh, 2001; Wisplinghoff et al., 2004; Leblebicioglu et al., 2007).”
BackgroundHorn, D. L., Ostrosky-Zeichner, L., Morris, M. I., Ullmann, A. J., Wu, C., Buell, D. N., Kovanda, L. L., & Cornely, O. A. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0843-0 · Cited by 69
How Biofilm Growth Affects Candida-Host Interactions
Eix, E. F., & Nett, J. E. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01437 · Cited by 79
Rhodotorula spp. isolated from blood cultures: clinical and microbiological aspects
de Almeida, G. M. D., Costa, S. F., Melhem, M. D. S. C., Motta, A. L., Szeszs, M. W., Miyashita, F., Pierrotti, L. C., Rossi, F., & Burattini, M. N. (2008) · Medical Mycology · doi:10.1080/13693780801972490 · Cited by 69
Screening for MRSA: A Flawed Hospital Infection Control Intervention
Wenzel, R. P., Bearman, G. M., & Edmond, M. B. (2008) · Infection Control and Hospital Epidemiology · doi:10.1086/593120 · Cited by 73
“comycin); and Candida species (10% of isolates resistant to first-generation triazoles).(14) Furthermore, by 2006, 15% of Pseudomonas aeruginosa isolates were resistant to imipenem,(15)”
BackgroundSelf-citationRomanowski, K., Zaborin, A., Valuckaite, V., Rolfes, R. J., Babrowski, T., Bethel, C., Olivas, A., Zaborina, O., & Alverdy, J. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030119 · Cited by 69
“commensal organism normally colonizes mucosal surfaces in an asymptomatic manner, it can become one of the most significant causes of a disabling and lethal infection [24,25,26].”
BackgroundSpellberg, B., Ibrahim, A. S., Lin, L., Avanesian, V., Fu, Y., Lipke, P., Otoo, H., Ho, T., & Edwards, Jr. (2008) · The Journal of Infectious Diseases · doi:10.1086/529204 · Cited by 70
“Because the mean time to onset of disseminated candidiasis is 22 days of hospitalization [12], the presence of protection by 1 week after the first dose of vaccine emphasizes the practicality of vaccinating acutely at-risk patients prior to disease onset.”
BackgroundMa, C.-F., Li, F.-Q., Shi, L.-N., Hu, Y.-A., Wang, Y., Huang, M., & Kong, Q.-Q. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-337 · Cited by 68
“currently ranks as the fourth and the seventh most common bloodstream pathogen in North American and European studies [3,4].”
BackgroundRapid diagnosis of candidaemia by real-time PCR detection of Candida DNA in blood samples
Wellinghausen, N., Siegel, D., Winter, J., & Gebert, S. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.007906-0 · Cited by 70
Management bundles for candidaemia: the impact of compliance on clinical outcomes
Takesue, Y., Ueda, T., Mikamo, H., Oda, S., Takakura, S., Kitagawa, Y., KOHNO, S., on behalf of the ACTIONs Project, Masuda, A., Yoshida, C., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku414 · Cited by 77
Bloodstream Infections in Hospitalized Children
Larrú, B., Gong, W., Vendetti, N., Sullivan, K. V., Localio, R. A., Zaoutis, T. E., & Gerber, J. S. (2016) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001057 · Cited by 69
“Healthcare-acquired blood stream infections (HAI) due to Gram-positive organisms have become increasingly frequent since the 1980s because of the increasing use of central venous catheters and are now the leading cause of nosocomial bacteremia.(10,11) Our study corroborates the predominance of Gram-positive pathogens,…”
BackgroundGiacobbe, D. R., Maraolo, A. E., Simeon, V., Magnè, F., Pace, M. C., Gentile, I., Chiodini, P., Viscoli, C., Sanguinetti, M., Mikulska, M., et al. (2020) · Mycoses · doi:10.1111/myc.13054 · Cited by 77
Both, A., Huang, J., Qi, M., Lausmann, C., Weißelberg, S., Büttner, H., Lezius, S., Failla, A. V., Christner, M., Stegger, M., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009304 · Cited by 81
Bacterial lipopolysaccharides variably modulate in vitro biofilm formation of Candida species
Bandara, H. M. H. N., Lam, O. L. T., Watt, R. M., Jin, L. J., & Samaranayake, L. P. (2010) · Journal of Medical Microbiology · doi:10.1099/jmm.0.021832-0 · Cited by 68
Canadian Clinical Practice Guidelines for Invasive Candidiasis in Adults
Bow, E. J., Evans, G., Fuller, J., Laverdière, M., Rotstein, C., Rennie, R., Shafran, S. D., Sheppard, D., Carle, S., Phillips, P., et al. (2010) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2010/357076 · Cited by 70
Nagao, M. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12083 · Cited by 68
Hällgren, A., Claesson, C., Saeedi, B., Monstein, H., Hanberger, H., & Nilsson, L. E. (2008) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2008.10.001 · Cited by 68
“However, in recent decades enterococci have become a leading cause of nosocomial infection in many countries (Bouza et al., 2004; Wisplinghoff et al., 2004).”
BackgroundNovel strategies to fightCandidaspecies infection
Rodrigues, M. E., Silva, S. M., Azeredo, J., & Henriques, M. (2014) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2014.974500 · Cited by 80
“…2003; Guery et al., 2009; Kullberg et al., 2011; Marchetti et al., 2004; Pappas et al., 2003; Tortorano et al., 2004; Van de Veerdonk et al., 2010; Wisplinghoff et al., 2004; Zaoutis et al., 2005), and represents a significant burden on the public health system in terms of patient management and…”
BackgroundVernachio, J. H., Bayer, A. S., Ames, B., Bryant, D., Prater, B. D., Syribeys, P. J., Gorovits, E. L., & Patti, J. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.511-518.2006 · Cited by 68
“Staphylococcus aureus and Staphylococcus epidermidis account for over half of all nosocomial bloodstream infections annually in the United States (30).”
BackgroundInfluentialAntifungals to treatCandida albicans
Moudgal, V. V., & Sobel, J. D. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.493875 · Cited by 85
“In the United States, Candida species are the fourth leading cause of nosocomial bloodstream infections, accounting for 8 -- 9% of isolates [1,2].”
BackgroundTaira, C. L., Okay, T. S., Delgado, A. F., Ceccon, M. E. J. R., de Almeida, M. T. G., & Negro, G. M. B. D. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-406 · Cited by 71
“Candida species are the third most common pathogen isolated from bloodstream infections of preterm infants and the fourth most common pathogen in paediatric intensive care unit (ICU) patients [3-5].”
BackgroundPereira, G. H., Müller, P. R., Szeszs, M. W., Levin, A. S., & Melhem, M. S. C. (2010) · Medical Mycology · doi:10.3109/13693780903580121 · Cited by 68
Pence, M. A., McElvania, E., Wallace, M. A., & Burnham, C. D. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2115-x · Cited by 71
“Candida species are responsible for nearly 10 % of nosocomial bloodstream infections in hospitals in the United States [1].”
BackgroundGarcía-de-la-Mària, C., Marco, F., Armero, Y., Soy, D., Moreno, A., del Río, A., Almela, M., Cervera, C., Ninot, S., Falces, C., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01011-09 · Cited by 68
“These organisms are the most common etiologic agents of bacteremia among hospitalized patients, and Staphylococcus epidermidis is isolated from 50% to 70% of catheter-related bloodstream infections (3, 28).”
BackgroundInsights on virulence from the complete genome of Staphylococcus capitis
Cameron, D. R., Jiang, J., Hassan, K. A., Elbourne, L. D. H., Tuck, K. L., Paulsen, I. T., & Peleg, A. Y. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00980 · Cited by 79
“…University, Building 76, Wellington Road, Clayton, Melbourne 3800, VIC, Australia anton.peleg@monash.edu Specialty section: This article was submitted to Evolutionary and Genomic Microbiology, a section of the journal Frontiers in Microbiology Received: 07 January 2015 Accepted: 03 September 2015…”
BackgroundQureshi, Z. A., Paterson, D. L., Pakstis, D. L., Adams‐Haduch, J. M., Sandkovsky, G., Sordillo, E. M., Polsky, B., Peleg, A. Y., Bhussar, M. K., & Doi, Y. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.09.009 · Cited by 75
Comparison of three preparatory methods for detection of bacteremia by MALDI-TOF mass spectrometry
Saffert, R. T., Cunningham, S. A., Mandrekar, J. N., & Patel, R. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.01.010 · Cited by 68
“Bloodstream infection (BSI) is associated with high morbidity and mortality (Wisplinghoff et al., 2004).”
BackgroundSeidl, K., Bayer, A. S., Fowler, V. G., McKinnell, J. A., Abdel Hady, W., Sakoulas, G., Yeaman, M. R., & Xiong, Y. Q. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01028-10 · Cited by 69
“Staphylococcus aureus is a leading cause of bacteremia and infective endocarditis (IE) throughout the industrialized world (18, 22, 42, 54).”
BackgroundHolmbom, M., Giske, C. G., Fredrikson, M. G., Balkhed, Å. Ö., Claesson, C., Nilsson, L. E., Hoffmann, M., & Hanberger, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166527 · Cited by 70
Guidelines for the prevention of the intravascular catheter‐related infections
(2003) · Nutrition in Clinical Practice · doi:10.1177/0115426503018001105e · Cited by 68
The Transcription Factor Homolog CTF1 Regulates β-Oxidation in Candida albicans
Ramírez, M. A., & Lorenz, M. C. (2009) · Eukaryotic Cell · doi:10.1128/ec.00206-09 · Cited by 67
“albicans can infect nearly any site in the body, the most serious manifestation, disseminated bloodstream infections, particularly affects immunocompromised individuals and is fatal in about 40% of cases (67).”
BackgroundUpdate on the epidemiology and diagnosis of invasive fungal infection
Cuenca‐Estrella, M., Bernal‐Martínez, L., Buitrago, M. J., Castelli, M. V., Gómez‐López, A., Zaragoza, Ó., & Rodríguez-Tudela, J. L. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(08)70016-5 · Cited by 76
“Candida is the fourth most common microorganism in bloodstream infections [18] and the incidence varies according to the study.”
BackgroundMolecular Methods for the Diagnosis of Invasive Candidiasis
Camp, I., Spettel, K., & Willinger, B. (2020) · Journal of Fungi · doi:10.3390/jof6030101 · Cited by 76
“have been referred to being the fourth most common cause of nosocomial blood stream infections [18].”
BackgroundChalkha, M., Akhazzane, M., Moussaid, F. Z., Daouı, O., Nakkabi, A., Bakhouch, M., Chtita, S., Elkhattabi, S., Housseini, A. I., & Yazidi, M. E. (2021) · New Journal of Chemistry · doi:10.1039/d1nj05621b · Cited by 70
Acinetobacter baumannii: emergence and spread in Israeli hospitals 1997–2002
重敏, 森., Weinberger, M., Siegman-Igra, Y., Lazarovitch, T., Ostfeld, I., Boldur, I., Samra, Z., Shula, H., Carmeli, Y., Rubinovitch, B., et al. (2005) · Journal of Hospital Infection · doi:10.1016/j.jhin.2005.01.007 · Cited by 67
“%) have been reported previously from Israel (54%).7 In the SCOPE project, 34% of patients with A. baumannii BSI died compared with 27% for all BSIs.3 A provocative matched cohort study claimed that A. baumannii BSIs are not associated with increased mortality rates in critically ill patients.13 In this study, crude m…”
BackgroundInfluentialStewart, E. J., Ganesan, M., Younger, J. G., & Solomon, M. J. (2015) · Scientific Reports · doi:10.1038/srep13081 · Cited by 81
“Coagulase-negative staphylococci are responsible for 31% of hospital-acquired bloodstream infections in the United States 26 .”
Metadata
- Authors
- Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B.
- Affiliations
- University of Cologne (DE)
- Virginia Commonwealth University (US)
- Corresponding author
- Edmond, M. B.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-08-01
- Volume
- 39
- Issue
- 3
- Pages
- 309-317
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2171155970
- Cited by
- 4,496
- References
- 42
- Citations by year
- 2026: 78 · 2025: 138 · 2024: 137 · 2023: 171 · 2022: 209 · 2021: 187 · 2020: 229 · 2019: 252 · 2018: 215 · 2017: 238 · 2016: 255 · 2015: 271 · 2014: 291 · 2013: 257 · 2012: 241
- FWCI
- 105.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- nosocomial bloodstream infection, nosocomial infections, antibiotic resistance, methicillin-resistant Staphylococcus aureus, vancomycin resistance, Enterococcus faecium, Enterococcus faecalis, coagulase-negative staphylococci, candidiasis, intensive care unit, neutropenic patients, infectious disease epidemiology, temporal trends
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Candidiasis, Child, Child, Preschool, Cross Infection, Drug Resistance, Microbial, Female, Humans, Infant, Male, Middle Aged, Population Surveillance, Prospective Studies, Staphylococcal Infections, United States, Causality, Incidence, Fungemia, Bacteremia, Gram-Negative Bacterial Infections, Gram-Positive Bacterial Infections, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.